| Literature DB >> 32420173 |
Xiaonong Chen1, Weigao Wang1, Anping Xiang1, Yuehong Li1.
Abstract
BACKGROUND: To explore the value of orthotopic spiral ileal bladder substitution (OSIBS) following radical cystectomy in treating bladder cancer patients by investigating the short- and long-term postoperative complications and assessing the quality of life in patients who had undergone OSIBS.Entities:
Keywords: Bladder cancer; Function Assessment of Cancer Therapy-Bladder Cancer Form (FACT-BL); Orthotopic spiral ileal bladder substitution (OSIBS); functional evaluation; radical cystectomy
Year: 2020 PMID: 32420173 PMCID: PMC7215050 DOI: 10.21037/tau.2020.03.16
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Figure 1The isolated ileal loop forms spiral urinary reservoir.
General data of participants and non-participants
| General data | Participants | Non-participants | P value |
|---|---|---|---|
| n | 68 | 25 | – |
| Males (%) | 64 (94.14) | 23 (92.00) | >0.05 |
| Age (years) | 57.4±9.3 | 58.2±10.3 | >0.05 |
| Education (years) | 12.1±4.2 | 11.5±4.1 | >0.05 |
| Surgical time (hours) | 3.4±0.5 | 3.8±0.4 | >0.05 |
| Hospital stay (days) | 22.3±2.9 | 21.8±3.1 | >0.05 |
Post-operative complications
| Period of complications | Post-operative complications | n |
|---|---|---|
| Early complications | Urinary leakage | 4 |
| Intestinal obstruction | 4 | |
| Poor incision healing | 2 | |
| Late complications | Urinary incontinence | 8 |
| Metabolic disorder | 0 | |
| Renal function impairment | 0 | |
| Urethral tumor recurrence | 1 | |
| Neobladder stones | 2 | |
| Total | 21 |
Urodynamics 3 and 6 months after surgery
| Item | 3 months after surgery | 6 months after surgery | t value | P value |
|---|---|---|---|---|
| Neobladder capacity (mL) | 285.03±35.01 | 365.02±45.11 | −3.050 | 0.002 |
| Post-voiding residual (mL) | 45.11±9.02 | 26.01±8.10 | −5.568 | 0.001 |
| Maximum flow rate (mL/s) | 10.71±1.32 | 11.36±1.41 | −0.850 | 0.050 |
Comparison of renal function before and after surgery
| Comparison of renal function | n | Serum Cr (μmol/L) | BUN (μmol/L) |
|---|---|---|---|
| Before surgery | 68 | 102.71±18.61 | 5.79±1.57 |
| After surgery | 68 | 106.24±21.33 | 6.01±1.87 |
| Difference | 3.53±20.18 | 6.01±1.87 | |
| t value | 1.305 | 0.358 | |
| P value | 0.196 | 0.764 |
BUN, blood urea nitrogen.
Comparison of electrolytes before and after surgery
| Comparison of electrolytes | N | K+ (mmol/L) | Na+ (mmol/L) | Ca+ (mmol/L) | Cl− (mmol/L) |
|---|---|---|---|---|---|
| Before surgery | 68 | 4.33±0.27 | 139.57±2.65 | 2.40±0.04 | 105.28±0.26 |
| After surgery | 68 | 4.28±0.17 | 140.47±2.94 | 2.37±0.07 | 106.18±0.48 |
| Difference | 0.05±1.13 | −0.90±3.01 | 0.03±0.12 | −0.52±0.47 | |
| t value | 1.347 | −1.748 | 1.097 | −1.701 | |
| P value | 0.169 | 0.144 | 0.319 | 0.154 |
Scores of different domains based on FACT-BL
| Domain (total score) | Scores |
|---|---|
| Physical well-being | 24.2±3.2 |
| Social/family well-being | 23.5±2.5 |
| Emotional well-being | 20.2±1.5 |
| Functional well-being | 23.9±2.1 |
| FACT-G (108) | 92±9.4 |
| Bladder cancer-specific template (48) | 32.8±4.1 |
| FACT-BL (156) | 124.8±13.4 |
FACT-BL, Function Assessment of Cancer Therapy-Bladder Cancer Form; FACT-G, Function Assessment of Cancer Therapy-Generic Scale.
Distribution of bladder cancer-specific template
| Satisfaction and urinary control | Never | Occasionally | Sometimes | Often | Always |
|---|---|---|---|---|---|
| I have trouble controlling my urine | 55 | 8 | 4 | 1 | 0 |
| I urinate more frequently than usual | 14 | 22 | 22 | 6 | 4 |
| I like the appearance of my body | 0 | 0 | 4 | 12 | 60 |
| I am interested in sex | 7 | 10 | 43 | 8 | 0 |
| (For men only) I can have and maintain an erection | 8 | 10 | 40 | 16 | 0 |